Gregory Bala

438 total citations
23 papers, 246 citations indexed

About

Gregory Bala is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Gregory Bala has authored 23 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Reproductive Medicine, 7 papers in Public Health, Environmental and Occupational Health and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Gregory Bala's work include Ovarian function and disorders (9 papers), Hypothalamic control of reproductive hormones (9 papers) and Estrogen and related hormone effects (4 papers). Gregory Bala is often cited by papers focused on Ovarian function and disorders (9 papers), Hypothalamic control of reproductive hormones (9 papers) and Estrogen and related hormone effects (4 papers). Gregory Bala collaborates with scholars based in Poland, Ireland and United States. Gregory Bala's co-authors include Anna Szeliga, Błażej Męczekalski, Marzena Maciejewska-Jeske, Anna Kostrzak, Agnieszka Podfigurna, Roman Smolarczyk, Michał Piotr Budzik, Eli Y. Adashi, Maciej Owecki and Monika Grymowicz and has published in prestigious journals such as International Journal of Molecular Sciences, Current Opinion in Pharmacology and Maturitas.

In The Last Decade

Gregory Bala

20 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Bala Poland 10 127 66 65 49 19 23 246
Sabine Naessén Sweden 8 137 1.1× 112 1.7× 59 0.9× 28 0.6× 59 3.1× 15 342
Kathleen P. McHugh United States 6 175 1.4× 141 2.1× 62 1.0× 25 0.5× 12 0.6× 7 319
Pablo Knoblovits Argentina 9 122 1.0× 53 0.8× 172 2.6× 133 2.7× 85 4.5× 21 357
Krasean Panyakhamlerd Thailand 10 34 0.3× 52 0.8× 93 1.4× 33 0.7× 36 1.9× 42 300
Jani Liimatta Finland 8 237 1.9× 97 1.5× 199 3.1× 130 2.7× 57 3.0× 19 472
Yuchen Wang China 10 24 0.2× 33 0.5× 96 1.5× 18 0.4× 35 1.8× 20 295
Lorna A. Marshall United States 11 259 2.0× 123 1.9× 36 0.6× 30 0.6× 29 1.5× 21 368
Zhilan Yang China 8 39 0.3× 45 0.7× 27 0.4× 57 1.2× 50 2.6× 15 289
M.T. Muñoz-Calvo Spain 9 60 0.5× 48 0.7× 93 1.4× 69 1.4× 58 3.1× 21 268
Laurence C. Udoff United States 10 200 1.6× 151 2.3× 89 1.4× 44 0.9× 108 5.7× 23 471

Countries citing papers authored by Gregory Bala

Since Specialization
Citations

This map shows the geographic impact of Gregory Bala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Bala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Bala more than expected).

Fields of papers citing papers by Gregory Bala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Bala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Bala. The network helps show where Gregory Bala may publish in the future.

Co-authorship network of co-authors of Gregory Bala

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Bala. A scholar is included among the top collaborators of Gregory Bala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Bala. Gregory Bala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szeliga, Anna, et al.. (2025). The Use of Stem Cells in Assisted Reproduction. Journal of Clinical Medicine. 14(19). 6942–6942.
2.
Męczekalski, Błażej, et al.. (2025). PCOS and Obesity: Contraception Challenges. PubMed. Volume 16. 43–58.
3.
Męczekalski, Błażej, et al.. (2025). A New Hope for Woman with Vasomotor Symptoms: Neurokinin B Antagonists. Journal of Clinical Medicine. 14(5). 1438–1438. 1 indexed citations
4.
Smolarczyk, Roman, Anna Szeliga, A. M. Duszewska, et al.. (2025). Foretelling the Future: Preimplantation Genetic Testing and the Coming of Polygenic Embryo Screening. Journal of Clinical Medicine. 14(11). 3885–3885.
5.
Duszewska, A. M., Marzena Maciejewska-Jeske, Anna Szeliga, et al.. (2024). The impact of water pollution on the health of older people. Maturitas. 185. 107981–107981. 21 indexed citations
6.
Bala, Gregory, et al.. (2024). Kisspeptin and Endometriosis—Is There a Link?. Journal of Clinical Medicine. 13(24). 7683–7683. 1 indexed citations
7.
Męczekalski, Błażej, Libera Troìa, Anna Kostrzak, et al.. (2023). Neuroendocrine disturbances in women with functional hypothalamic amenorrhea: an update and future directions. Endocrine. 84(3). 769–785. 8 indexed citations
8.
Męczekalski, Błażej, et al.. (2023). PCOS in Adolescents—Ongoing Riddles in Diagnosis and Treatment. Journal of Clinical Medicine. 12(3). 1221–1221. 30 indexed citations
9.
Grymowicz, Monika, Anna Kostrzak, Michał Piotr Budzik, et al.. (2023). Bones and Hormones: Interaction between Hormones of the Hypothalamus, Pituitary, Adipose Tissue and Bone. International Journal of Molecular Sciences. 24(7). 6840–6840. 20 indexed citations
10.
Bala, Gregory, et al.. (2023). Managing Early Onset Osteoporosis: The Impact of Premature Ovarian Insufficiency on Bone Health. Journal of Clinical Medicine. 12(12). 4042–4042. 13 indexed citations
11.
Szeliga, Anna, et al.. (2023). Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies. Journal of Clinical Medicine. 12(18). 5915–5915. 35 indexed citations
12.
Szeliga, Anna, Agnieszka Podfigurna, Gregory Bala, & Błażej Męczekalski. (2023). Decreased neurokinin B as a risk factor of functional hypothalamic amenorrhea. Gynecological Endocrinology. 39(1). 2216313–2216313. 4 indexed citations
13.
Bala, Gregory, et al.. (2022). Stress, kisspeptin, and functional hypothalamic amenorrhea. Current Opinion in Pharmacology. 67. 102288–102288. 24 indexed citations
14.
Szeliga, Anna, Agnieszka Podfigurna, Gregory Bala, & Błażej Męczekalski. (2022). The influence of estro-progestin therapy on neurohormonal activity in functional hypothalamic amenorrhea. Gynecological Endocrinology. 38(11). 997–1002. 1 indexed citations
15.
Szeliga, Anna, Błażej Męczekalski, Anna Kostrzak, et al.. (2021). Menopause in women with schizophrenia, schizoaffective disorder and bipolar disorder. Maturitas. 152. 57–62. 15 indexed citations
16.
Męczekalski, Błażej, Anna Szeliga, Marzena Maciejewska-Jeske, et al.. (2021). Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism. Gynecological Endocrinology. 37(8). 677–682. 22 indexed citations
17.
Szeliga, Anna, Agnieszka Podfigurna, Gregory Bala, & Błażej Męczekalski. (2019). Kisspeptin and neurokinin B analogs use in gynecological endocrinology: where do we stand?. Journal of Endocrinological Investigation. 43(5). 555–561. 19 indexed citations
18.
Słopień, Radosław, Maciej Owecki, Agnieszka Słopień, Gregory Bala, & Błażej Męczekalski. (2019). Climacteric symptoms are related to thyroid status in euthyroid menopausal women. Journal of Endocrinological Investigation. 43(1). 75–80. 13 indexed citations
19.
Maciejewska-Jeske, Marzena, Anna Szeliga, A Czyźyk, et al.. (2018). New mutation causing androgen insensitivity syndrome – a case report and review of literature. Gynecological Endocrinology. 35(4). 294–297. 4 indexed citations
20.
Błażewska, K. M., et al.. (1992). [A case of idiopathic hypercalcemia (hypersensitivity to vitamin D 3].. PubMed. 45(5-6). 229–32. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026